Results 81 to 90 of about 3,170,441 (213)

Perioperative hyperfibrinolysis – physiology and pathophysiology

Brazilian Journal of Anesthesiology, 2021
Introduction and objectives: The role of the anesthesiologist in the perioperative management of hemostasis has attracted increasing attention. The fibrinolytic system participates in hemostasis, removing clots after repair of the vascular injury.
David Silveira Marinho
doaj  

Uso tópico de agente antifibrinolítico na redução do sangramento após revascularização cirúrgica do miocárdio Topical use of antifibrinolytic agent to reduce postoperative bleeding after coronary artery bypass surgery

Brazilian Journal of Cardiovascular Surgery, 2009
OBJETIVO: Verificar o efeito do uso tópico do ácido epsilon-aminocapróico (AEAC), aplicado na cavidade pericárdica, na redução do sangramento e necessidade de transfusão sanguínea no pós-operatório de revascularização cirúrgica do miocárdio.
João Roberto Breda, Danilo Bortoloto Gurian, Ana Silvia Castaldi Ragognetti Breda, Adriano Meneghine, Andréa Cristina de Oliveira Freitas, Leandro Mattos Luongo, Luiz Carlos de Abreu, Adilson Casemiro Pires   +7 more
doaj   +1 more source

Preventive and therapeutic effects of tranexamic acid on postpartum bleeding [PDF]

Reviews in Clinical Medicine, 2015
Postpartum hemorrhage is among the leading causes of maternal mortality throughout the world. Severe blood loss contributes to  the increased blood transfusion risk with its concerned inherent adverse events and therefore increased rate of emergency re ...
Samaneh Solltani, Masoumeh Mirteimouri, Ameneh Movahedian, Nushin Chalakinia   +3 more
doaj   +1 more source

An update on the management of anticoagulated patients programmed for dental extractions and surgery [PDF]

, 2008
Oral anticoagulants (OACs) antagonizing vitamin K - fundamentally sodium warfarin and acenocoumarol - are widely used for preventing arterial thromboembolism in patients with atrial fibrillation and/or heart valve prostheses, and for the treatment and ...
Gavaldá Esteve, Carmen, Jiménez Soriano, Yolanda, Margaix Muñoz, María, Poveda Roda, Rafael, Sarrión Pérez, María Gracia   +4 more
core  

Effect of Prophylactic Intravenous Tranexamic Acid on Blood Loss After Vaginal Delivery: A Randomized Control Study

Health Science Reports
Background and Aim To determine the effect of prophylactic intravenous tranexamic acid on blood loss after vaginal delivery in women at low risk of postpartum hemorrhage.
Sajana Shrestha, Shelisha Uprety, Ravi Shah, Brinda Kharel   +3 more
doaj   +1 more source

Fibrinolysis and bleeding of unknown cause

Research and Practice in Thrombosis and Haemostasis, 2021
Patients with bleeding of unknown cause (BUC) present with a variety of mild to moderate bleeding symptoms, but no hemostatic abnormalities can be found. Hyperfibrinolysis is rarely evaluated as the underlying cause for bleeding in clinical practice, and
Dino Mehic, Ingrid Pabinger, Cihan Ay, Johanna Gebhart   +3 more
doaj   +1 more source

A Bio‐Adaptive Janus‐Adhesive Dressing with Dynamic Lubrication Overlayer for Prevention of Postoperative Infection and Adhesion

Advanced Science, Volume 12, Issue 18, May 15, 2025.
Slippery‐adhesive Janus gel dressing exhibits both stable tissue adhesive and outstanding efficiency in repelling physiological fluids. As a physical barrier, a liquid‐infused surface with a dynamic lubrication overlayer possesses excellent antibiofouling properties, making it highly effective in preventing bacterial infections and postoperative tissue
Yuan Gao, Junchang Guo, Shuangyang Li, Liansong Ye, Binyang Lu, Jiaxin Liu, Jing Luo, Yijia Zhu, Liuxiang Chen, Tingfa Peng, Jinlong Yang, Dehui Wang, Chaoming Xie, Xu Deng, Bing Hu   +14 more
wiley   +1 more source

Topical vs. intravenous administration of tranexamic acid in knee arthroplasty and prevalence of deep venous thrombosis: a randomized clinical trial

Jornal Vascular Brasileiro
Background Tranexamic acid (TXA) is widely used in orthopedic surgery to reduce perioperative bleeding. Since TXA inhibits fibrinolysis, there is concern that it may increase the risk of thromboembolic events. Objectives To verify the prevalence of deep
Ari Zekcer, Ricardo Del Priori, Clauber Tieppo, Ricardo Soares da Silva, Nilson Roberto Severino   +4 more
doaj   +1 more source

Management of Antithrombotic Agents in Oral Surgery Maria Martinez and Dimitrios A. Tsakiris *

Dentistry Journal, 2015
Systemic anticoagulation with intravenous or oral anticoagulants and antiplatelet agents is an efficient treatment against thromboembolic or cardiovascular disease.
Maria Martinez, Dimitrios A. Tsakiris
doaj   +1 more source

Treatment of Bleeding Episodes With Efanesoctocog Alfa in Previously Treated Patients With Severe Hemophilia A in the Phase 3 XTEND‐1 Study

American Journal of Hematology, Volume 100, Issue 5, Page 813-820, May 2025.
ABSTRACT Despite therapeutic advances, people with hemophilia experience bleeds. These may be life‐threatening, result in permanent joint damage, chronic pain, difficulties with mobility/daily activities, and impact quality of life. In the XTEND‐1 study (NCT04161495), once‐weekly efanesoctocog alfa (50 IU/kg) prophylaxis provided highly effective bleed
Angela C. Weyand, Sandrine Meunier, Nobuaki Suzuki, Linda Bystrická, Graham Neill, Lydia Abad‐Franch, Annemieke Willemze, Alberto Tosetto   +7 more
wiley   +1 more source